The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability

Biochemical Journal

Volumn 446, Issue 1, 2012, Pages 113-123

  Chang, Elizabeth T ^a,b   Donahue, James M ^a,b   Xiao, Lan ^a,b   Cui, Yuhong ^a,b   Rao, Jaladanki N ^a,b   Turner, Douglas J ^a,b   Twaddell, William S ^a   Wang, Jian Ying ^a,b   Battafar, Richard J ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

3 untranslated region; Apoptosis; CUG binding protein 1 (CUG BP1); mRNA stability; Post transcriptional regulation; Survivin

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN; RNA BINDING PROTEIN CUG BP1; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3' UNTRANSLATED REGIONS; APOPTOSIS; CAMPTOTHECIN; CELL LINE, TUMOR; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 84864770000     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120112     Document Type: Article

References (30)

1. Siegel, R., Ward, E., Brawley, O. and Jemal, A. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Ca-Cancer J. Clin. 61, 212-236
2. Chang, E., Donahue, J., Smith, A., Hornick, J., Rao, J. N., Wang, J. Y. and Battafarano, R. J. (2010) Loss of p53, rather than β-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. J. Thorac. Cardiovasc. Surg. 140, 225-232
3. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C. and Altieri, D. C. (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584 (Pubitemid 28563719)
4. Grabowski, P., Kuhnel, T., Muhr-Wilkenshoff, F., Heine, B., Stein, H., Hopfner, M., Germer, C. T. and Scherubl, H. (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer. 88, 115-119 (Pubitemid 36241227)
5. Ikeguchi, M., Yamaguchi, K. and Kaibara, N. (2003) Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer. Tumour Biol. 24, 40-45 (Pubitemid 36578817)
6. Kato, J., Kuwabara, Y., Mitani, M., Shinoda, N., Sato, A., Toyama, T., Mitsui, A., Nishiwaki, T., Moriyama, S., Kudo, J. and Fujii, Y. (2001) Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int. J. Cancer. 95, 92-95 (Pubitemid 32187079)
7. Vallböhmer, D., Peters, J. H., Oh, D., Kuramochi, H., Shimizu, D., Demeester, S. R., Hagen, J. A., Chandrasoma, P. T., Danenberg, K. D., DeMeester, T. R. and Danenberg, P. (2005) Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery 138, 701-706
8. Parenti, A., Leo, G., Porzionato, A., Zaninotto, G., Rosato, A. and Ninfo, V. (2006) Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis. Hum. Pathol. 37, 16-22 (Pubitemid 41790498)
9. Vallböhmer, D., Kuhn, E., Warnecke-Eberz, U., Brabender, J., Hoffmann, A. C., Metzger, R., Baldus, S. E., Drebber, U., Hoelscher, A. H. and Schneider, P. M. (2008) Failure of downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 9, 681-690
10. Zhang, T., Otevrel, T., Gao, Z., Ehrlich, S. M., Fields, J. Z. and Boman, B. M. (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664-8667 (Pubitemid 34013874)
11. Cosgrave, N., Hill, A. D. and Young, L. S. (2006) Growth factor-dependent regulation of survivin by c-myc in human breast cancer. J. Mol. Endocrinol. 37, 377-390 (Pubitemid 46085164)
12. Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D. et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res. 12, 11-19 (Pubitemid 43166170)
13. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J. and Murphy, M. (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247-3257 (Pubitemid 34953189)
14. Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R. et al. (2002) Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613-2622 (Pubitemid 34478319)
15. Timchenko, N. A., Cai, Z. J., Welm, A. L., Reddy, S., Ashizawa, T. and Timchenko, L. T. (2001) RNA CUG repeats sequester CUG-BP1 and alter protein levels and activity of CUG-BP1. J. Biol. Chem. 276, 7820-7826
16. Zhang, L., Lee, J. E., Wilusz, J. and Wilusz, C. J. (2008) The RNA-binding protein CUG-BP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J. Biol. Chem. 283, 22457-22463
17. Iakova, P., Wang, G. L., Timchenko, L., Michalak, M., Pereira-Smith, O. M., Smith, J. R. and Timchenko, N. A. (2004) Competition of CUG-BP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 23, 406-417 (Pubitemid 38294505)
18. Vaira, V., Lee, C. W., Goel, H. L., Basari, S., Languino, L. R. and Altieri, D. C. (2007) Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 26, 2678-2684 (Pubitemid 46663841)
19. Donahue, J. M., Chang, E. T., Xiao, L., Wang, P. Y., Rao, J. N., Turner, D. J., Wang, J. Y. and Battafarano, R. J. (2011) The RNA binding protein HuR stabilizes survivin mRNA in human esophageal epithelial cells. Biochem. J. 437, 89-96
20. Tsuda, K., Kuwasako, K., Takahashi, M., Someya, T., Inoue, M., Terada, T., Kobayashi, N., Shirouzu, M., Kigawa, T., Tanaka, A. et al. (2009) Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. Nucleic Acids Res. 37, 5151-5166
21. Rattenbacher, B., Beisang, D., Wiesner, D. L., Jeschke, J. C., von Hohenberg, M., St Louis-Vlasova, I. A. and Bohjanen, P. R. (2010) Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol. Cell. Biol. 30, 3970-3980
22. Xiao, L., Cui, Y. H., Rao, J. N., Zou, T., Liu, L., Smith, A., Turner, D. J., Gorospe, M. and Wang, J. Y. (2011) Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines. Mol. Biol. Cell 22, 3055-3069
23. Sheth, U. and Parker, R. (2003) Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300, 805-808 (Pubitemid 36532117)
24. Parker, R. and Sheth, U. (2007) P bodies and the control of mRNA translation and degradation. Mol. Cell 25, 635-646 (Pubitemid 46341926)
25. Zhou, H., Yang, L., Li, H., Li, L. and Chen, J. (2009) Residues that affect human Argonaute2 concentration in cytoplasmic processing bodies. Biochem. Biophys. Res. Commun. 378, 620-624
26. Takimoto, K., Wakiyama, M. and Yokoyama, S. (2009) Mammalian GW182 contains multiple Argonaute-binding sites and functions in microRNA-mediated translational repression. RNA 15, 1078-1089
27. Jagannath, A. and Wood, M. J. (2009) Localization of small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2. Mol. Biol. Cell 20, 521-529
28. Balagopal, V. and Parker, R. (2009) Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Curr. Opin. Cell Biol. 21, 403-408
29. Decker, C. J., Teixeira, D. and Parker, R. (2007) Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae. J. Cell Biol. 179, 437-449 (Pubitemid 350074789)
30. Gareau, C., Fournier, M. J., Filion, C., Coudert, L., Martel, D., Labelle, Y. and Mazroui, R. (2011) p21 upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis. PloS ONE 6, 1-14